The Hong Kong Exchanges and Clearing Limited (HKEX) is a leading global financial market operator and the sole stock exchange in Hong Kong. In 2018, HKEX implemented Chapter 18A Listing Reform to attract more high-growth and innovative companies to list on its exchange, particularly in the biotech sector, allowing pre-revenue and pre-profit biotech companies to be listed - a first in Asia and proof of Hong Kong's commitment to developing a biotech ecosystem. Here is what you can expect:
- Understand the investor landscape in Hong Kong.
- Learn the opportunities and challenges of listing on HKEX.
- Regulatory hurdles to navigate and investor expectations to meet.
- Listing requirements and procedures.
- Network with other key industry players and potential investors.
Want to maximize your business potential on the HKEX? Join us for this exclusive HKEX workshop at BIOHK2023 as we bring you the leading experts in the field to foster a collaborative environment for everyone to find opportunities in Hong Kong as a burgeoning biotech hub.
There is no better time to align your goals and maximize your returns with other parites in the future of biotech. The opportunity awaits you.